Did You Know...
...that when IBM conducted a market study of Chester Carlson's invention in 1959, the company concluded that it would take only 5000 units of his new product to saturate the market? IBM therefore declined to be part of the new product introduction. Too bad for IBM. Carlson's invention was the xerography process, and his new product was the beginning of the Xerox Corporation. It is estimated that every day, worldwide, 3,000,000,000 copies are made!!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7385023 | Cancer immunotherapy and diagnosis using cytochrome P450 1B1 The invention provides methods for conducting cancer immunotherapy and diagnosis using cytochrome P450 1B1 and peptide fragments thereof. ... | 06/10/2008 |
| 7255877 | Fenofibrate microparticles Fenofibrate microparticles are prepared using a combination of surface modifiers with a phospholipid. Particle size growth and stability are controlled while significantly smaller sized fenofibrate particles are produced. ... | 08/14/2007 |
| 7220402 | Alpha-fetoprotein peptides and uses for imaging The invention provides diagnostic procedures wherein the presence or absence of a cell-proliferating disorder, e.g., a breast cancer, may be determined. The imaging agents of the invention include alpha-fetoprotein hydrophilic analogs which have been determined to t... | 05/22/2007 |
| 7012825 | Combined AC-DC to DC converter The invention relates to a combined AC-DC to DC converter. The converter provides the option of coupling to an AC supply source with at least one phase and the further option of coupling to at least one DC supply source. The converter obtains supply from at least on... | 03/14/2006 |
| 6991796 | Platlet glycoprotein IBα fusion polypeptides and methods of use thereof The present invention provides compositions and methods for treating or preventing vascular-associated disorders. ... | 01/31/2006 |
| 6974574 | Methods of inducing an HIV specific response using a Vpr-specific epitope The invention features an immunogenic composition containing a frequently-recognized epitope of an HIV-1 accessory protein such as Vpr and methods of inducing an immune response using such an epitope. The epitope peptide contains the amino acid sequence ALIRILQQL of... | 12/13/2005 |
| 6959558 | Systems and methods for head pressure control The present invention relates to systems and methods for controlling head pressure in a vapor compression system, e.g. in a precision air conditioning system. One embodiment of the invention provides a method for regulating working fluid flow in a vapor compression ... | 11/01/2005 |
| 6894622 | Method and apparatus for delivering uninterrupted power An uninterruptible power supply that provides power to an electrical device, the uninterruptible power supply that includes a first housing; a cover plate that includes a plurality of electrical outlets located on a surface of the cover plate and said cover plate is... | 05/17/2005 |
| 6886493 | Motor assisted swivel A motor assisted swivel is disclosed which aids in proper rotation of a swivel in a tether system for animal testing. The swivel may have any number of fluid conduits or electrical or optical leads. A switching mechanism determines a direction of rotation of the tet... | 05/03/2005 |
| 6880349 | Rack-mounted equipment cooling A gas distribution unit for use in a rack, that holds rack-mounted equipment that produces heat during operation, includes a housing defining a cavity, an exhaust port in a top wall of the housing, and at least one intake port configured to provide fluid communicati... | 04/19/2005 |
| 6867655 | Fast-acquisition phase-locked loop The invention provides techniques for compensating for current leakage from a loop filter during off times of a PLL between on times of the PLL, e.g., when a cell phone is in paging mode. The leakage current is compensated by providing offsetting charge to ensure th... | 03/15/2005 |
| 6849256 | Inhibition of pathogens by probiotic bacteria Composition containing a lactic acid-producing bacterial strain, e.g., Bacillus coagulans for inhibition of pathogenic bacterial infections. Spores or extracellular products produced by the bacterial strains are also useful as inhibitory agents. ... | 02/01/2005 |
| 6845262 | Low-field MRI A method of imaging using magnetic resonance includes administering hyperpolarized noble gas to a subject in a region to be imaged, applying a magnetic field of a magnitude between about 0.0001 Tesla and about 0.1 Tesla to the subject at least in the region of the s... | 01/18/2005 |
| 6399753 | Striated-specific muscle cell polypetides Aortic-preferentially-expressed gene-1 (APEG-1) and striated muscle preferentially expressed (SPEG) polypeptide, DNA sequences encoding and controlling the transcription of the APEG-1/SPEG encoding gene, methods of diagnosing vascular injury, methods of c... | 06/04/2002 |
| 5952226 | Hypoxia responsive EPO producing cells A device and method for delivery of EPO to a patient using an implanted device that continuously releases EPO.... | 09/14/1999 |
| 5935849 | Methods and compositions of growth control for cells encapsulated within bioartificial organs This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth s... | 08/10/1999 |
| 5871767 | Methods for treatment or prevention of neurodegenerative conditions using immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core A method for treatment of a neurodegenerative condition in a patient comprising implanting in the patient at least one immunoisolatory vehicle comprising a corc comprising a volume of at least 1 μl and at least 104 living cells which secrete a... | 02/16/1999 |
| 5869077 | Methods for treating diabetes by delivering insulin from biocompatible cell-containing devices A method for treating diabetes in a patient comprising subcutaneously implanting in the patient at least one immunoisolatory vehicle comprising a core comprising a volume of at least 1 μl and at least about 104 living cells which secrete insul... | 02/09/1999 |
| 5858747 | Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers Methods and compositions are provided for controlling cell distribution within an implantable bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth ... | 01/12/1999 |
| 5843431 | Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation Methods and compositions are provided for controlling cell distribution within an implantable bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth ... | 12/01/1998 |
| 5800829 | Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core A method of making an immunoisolatory vehicle comprised of a core comprising living cells dispersed in a biocompatible matrix is disclosed, the cells being capable of secreting a biologically active product or of providing a metabolic or immunologic funct... | 09/01/1998 |
| 5800828 | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products Immunoisolatory vehicles having a core and a surrounding jacket are disclosed, the core having a volume in excess of 1 μl and at least about 104 living cells capable of secreting a biologically active product or of providing a biological funct... | 09/01/1998 |
| 5776747 | Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth s... | 07/07/1998 |
